Zscaler shares fall sharply on weaker-than-expected growth forecast

Zscaler fell more than 31% after issuing softer-than-expected forward guidance, with fiscal Q4 revenue outlook of $875 million to $878 million below the $879 million consensus and preliminary fiscal 2027 growth guidance of 16% to 17% versus prior Street expectations near 19% to 20%. Fiscal Q3 results were solid, with EPS of $1.08 versus $1.01 expected and revenue of $850.5 million versus $835.5 million expected, but investors focused on the growth slowdown. Management also signaled a more cautious outlook for organic ARR growth and new logo expansion, contributing to the sharp selloff.

Analysis

The market is not punishing a miss; it is repricing the terminal growth regime. The key signal is that Zscaler’s forward guide implies the business is transitioning from a land-grab model into a more mature optimization phase, where new-logo intensity and sales efficiency matter more than product breadth. In cybersecurity, that typically compresses valuation multiples faster than the actual revenue deceleration because the market front-runs slower billings comp and lower incremental ARR productivity.

The second-order issue is competitive: if management is already signaling caution on new logo growth and sales turnover is disrupting execution, the opening is less for a single direct rival to take share immediately and more for buyers to slow purchasing and extend vendor consolidation cycles. That favors platform-heavy incumbents with larger installed bases and stronger procurement leverage, while smaller point-solution vendors may face longer sales cycles as CISOs wait for clearer budget visibility. Red Canary’s slower growth versus core also matters because it weakens the acquisition narrative that higher-growth tuck-ins can offset core moderation.

This kind of reset can reverse only if the next 1-2 quarters show organic net new ARR re-acceleration without heavy discounting. The nearer-term catalyst is not revenue; it is management credibility around pipeline quality, rep productivity, and whether the new sales leadership can stabilize execution before FY27 expectations become embedded. If organic ARR growth holds near the high-teens while opex discipline stays intact, the stock can rebound sharply off this washout; if not, the multiple likely remains under pressure for months, not days.

The contrarian angle is that the selloff may overshoot the actual earnings power deterioration. A 16%-17% FY27 growth framework is still robust for a large-cap security franchise, and if the market was discounting closer to 20%, the repricing could eventually create a tradable bottom once consensus numbers fully reset. The risk is that investors anchor on the headline growth reset and ignore that lower growth could also come with better capital efficiency and less reinvestment drag, which would matter more for long-duration holders than momentum accounts.

Key Decisions for Investors

• Short ZS on any post-gap bounce over the next 3-10 trading days; use a tight stop above the first failed retracement because the setup is a valuation reset, not a temporary miss.
• Pair trade: long PANW / short ZS for 1-3 months to express relative execution quality within cybersecurity; PANW should benefit if buyers rotate toward platform scale and away from decelerating growth stories.
• Buy ZS put spreads 1-2 expiries out rather than outright puts; the skew is likely expensive after the move, but further multiple compression is still plausible if guidance gets revised lower again.
• For longer-term accounts, wait 1-2 quarters before buying the dip; only consider long exposure if organic net new ARR re-accelerates and management shows sales turnover is behind them.
• If you must own the group, rotate from high-multiple growth security names into cash-generative incumbents with steadier billings visibility; the next leg of the cycle should reward execution and operating leverage over headline ARR growth.